Search - tctmd.com

Displaying 61 - 80 of 84

Sort: Relevancy | Date

News Daily News

New Review Probes Possibility of CVD Prevention Without Aspirin

Michael O'Riordan

July 04, 2018

News Daily News

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Michael O'Riordan

June 12, 2018

News Daily News

Outrunning Your Genes: Exercise Offsets CVD Events Among High-Risk Subjects

Michael O'Riordan

April 10, 2018

News Daily News

One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL

Michael O'Riordan

February 12, 2018

News Conference News AHA 2017

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Michael O'Riordan

November 13, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

Shelley Wood

November 02, 2017

News Daily News

NOAC Bleeding Risk Rises With Several Drug Combinations

Michael O'Riordan

October 06, 2017

News Daily News

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Michael O'Riordan

September 29, 2017

News Daily News

Betrixaban Approved for Prevention of VTE

Michael O'Riordan

June 23, 2017

News Conference News EuroPCR 2017

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

Michael O'Riordan

May 24, 2017

News Daily News

Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows

Michael O'Riordan

March 31, 2017

News Daily News

Timing and Dose Matters When It Comes to Statin Therapy Before CABG Surgery

Michael O'Riordan

March 16, 2017

News Conference News CRT 2017

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

Michael O'Riordan

February 20, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Features

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Shelley Wood

December 30, 2016

News Daily News

FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm

Michael O'Riordan

October 11, 2016

News Daily News

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Michael O'Riordan

October 07, 2016

News Conference News ESC 2016

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

Michael O'Riordan

August 28, 2016

Advertisement

New Review Probes Possibility of CVD Prevention Without Aspirin

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Outrunning Your Genes: Exercise Offsets CVD Events Among High-Risk Subjects

One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Live From Denver: TCT 2017, Day Four

NOAC Bleeding Risk Rises With Several Drug Combinations

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Betrixaban Approved for Prevention of VTE

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows

Timing and Dose Matters When It Comes to Statin Therapy Before CABG Surgery

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content